Author

K. C. Fogg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:imaging· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1

Frequent Co-Authors

I. A. Cadena· 4 shared C. G. Harris· 3 shared M. A. Jenne· 3 shared W. E. Rochefort· 3 shared A. Almer· 2 shared M. R. Buchanan· 2 shared N. Obasi· 2 shared A. N. Galindo· 1 shared

Activity by Year

2022-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersBioengineering

I. A. Cadena

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Empowering high-throughput high-content analysis of 3D tumor models: Open-source software for automated non-confocal image analysis

N. Wiggin, C. J. Cook, M. Black, I. A. Cadena, S. Rahal-Arabi, K. C. Fogg

This paper develops open-source software for automated analysis of 3D tumor models using non-confocal microscopy, achieving accurate drug sensitivity measurements and significantly reducing processing time.

bioRxiv · Feb 20, 2024 · PreprintBioengineering

Development of a 3D in vitro human-sized model of cervical dysplasia to evaluate the delivery of ethyl cellulose-ethanol injection for the treatment of cervical dysplasia ablation

I. A. Cadena, G. Adhikari, A. Almer, M. A. Jenne, N. Obasi, N. F. S. Zurita, W. E. Rochefort, J. L. Mueller, K. C. Fogg

This study develops a 3D in vitro model of cervical dysplasia to evaluate the efficacy of EC-ethanol injection for treating cervical dysplasia ablation.

bioRxiv · Feb 20, 2024 · PreprintBioengineering

Engineering a three-dimensional multilayer multicellular model of endometrial cancer for high throughput drug screening and novel treatment methods

I. A. Cadena, C. Rowlands, M. R. Buchanan, M. A. Jenne, B. Keefe, A. Almer, N. Obasi, C. G. Harris, W. E. Rochefort, B. E. Givens, K. C. Fogg

This paper develops a 3D multilayer multicellular hydrogel model of endometrial cancer for drug screening and treatment development, showing improved microvessel formation and cancer invasion compared to Matrigel.

bioRxiv · Feb 20, 2024 · PreprintBioengineering

Statistical Optimization of Hydrazone-Crosslinked Hyaluronic Acid Hydrogels for Protein Delivery

E. A. Mozipo, A. N. Galindo, J. D. Khachatourian, C. G. Harris, J. Dorogin, V. R. Spaulding, M. R. Ford, M. Singhal, K. C. Fogg, M. H. Hettiaratchi

The paper optimizes hydrazone-crosslinked hyaluronic acid hydrogels for protein delivery using design of experiments, identifying an optimal formulation that meets specific physicochemical and functional criteria.

bioRxiv · Jul 14, 2023Bioengineering

Engineering High Throughput Screening Platforms of Cervical Cancer

I. A. Cadena, M. R. Buchanan, C. G. Harris, M. A. Jenne, W. E. Rochefort, D. Nelson, K. C. Fogg

This paper develops a multicellular 3D platform for cervical cancer that integrates with high throughput drug screening to assess anti-metastatic and anti-angiogenic drug efficacy.

bioRxiv · Oct 16, 2022Bioengineering